Soldiers with blast-related TBI at risk for pituitary dysfunction

Soldiers suffering from traumatic brain injury (TBI) caused by an explosive blast had a higher rate of anterior pituitary dysfunction than people who sustained a non-blast TBI, suggesting pituitary dysfunction is a particular problem after blast exposure, according to a study published online Sept. 24 in Annals of Neurology.

“Our results suggest that all patients after moderate to severe [blast TBI] should undergo endocrine assessment,” wrote Anthony P. Goldstone MD, PhD, of Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, and colleagues.

Findings were based on the U.K. Blast Injury Outcome Study of Armed Forces Personnel (UK BIOSAP) and included 19 male soldiers with moderate to severe blast TBI. A group of 39 civilian males with moderate to severe non-blast TBI served as the control group. All patients received structural brain MRI, including diffusion tensor imaging (DTI), and underwent dynamic endocrine assessment between two and 48 months after injury.

Results showed that six of the 19 soldiers (32 percent) had anterior pituitary dysfunction compared with only one (2.6 percent) of the non-blast TBI controls. The soldiers had a range of conditions, including hyperprolactinemia, growth hormone deficiency, adrenocorticotropic hormone deficiency, and gonadotrophin deficiency.

DTI measures of white matter structure showed the cerebellum and corpus callosum sustained greater traumatic axonal injury in soldiers with pituitary dysfunction than in those without, according to Goldstone and colleagues. Soldiers with pituitary dysfunction were also more likely to have skull or facial fractures and worse cognitive function.

“Blast appears to produce a distinct pattern of TBI, although the mechanism by which blast injury damages the brain remains unclear, limiting our ability to identify those patients at high risk of pituitary dysfunction,” wrote the authors. They suggested that all patients with moderate to severe blast TBI should routinely have comprehensive assessment of endocrine function.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup